Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

• मुख्य लेखकों: Yanru Wang (लेखक), Xiaojie Jin (लेखक), Qin Fan (लेखक), Chenghao Li (लेखक), Min Zhang (लेखक), Yongfeng Wang (लेखक), Qingfeng Wu (लेखक), Jiawei Li (लेखक), Xiuzhu Liu (लेखक), Siyu Wang (लेखक), Yu Wang (लेखक), Ling Li (लेखक), Jia Ling (लेखक), Chaoxin Li (लेखक), Qianqian Wang (लेखक), Yongqi Liu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. Nevertheless, the regulated mechanisms of HSBDF...